Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Open-label, Phase 1 Drug Drug Interaction study between Tacrolimus and SCY-078 in Healthy male volunteers

Next Previous
X
Search
Trial Profile

An Open-label, Phase 1 Drug Drug Interaction study between Tacrolimus and SCY-078 in Healthy male volunteers

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 17 Nov 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ibrexafungerp (Primary) ; Tacrolimus
  • Indications Aspergillosis; Candidiasis; Vulvovaginal candidiasis
  • Focus Pharmacokinetics

    • Most Recent Events

    • 27 Sep 2017 Results presented at the 18th Congress of the European Society for Organ Transplantation
    • 25 Apr 2017 Results presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases
    • 12 Apr 2017 According to an SCYNEXIS media release, data from this study will be presented at the 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top